- 专利标题： PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS
-
申请号： US16273706申请日： 2019-02-12
-
公开(公告)号： US20190177300A1公开(公告)日： 2019-06-13
- 发明人: Jolie Anne Bastian , Joshua Ryan Clayton , David Andrew Coates , Daniel Jon Sall , Timothy Andrew Woods
- 申请人： Eli Lilly and Company
- 主分类号： C07D401/14
- IPC分类号： C07D401/14 ; A61K31/4184 ; A61P1/00 ; A61P19/02 ; C07D403/14 ; A61K31/4439 ; C07D403/12 ; A61P37/00
摘要：
The present invention provides compounds of the formula below (I′): where R, and R1-R3 are as described herein, methods of treating patients for certain types of autoimmune diseases and cancer, and processes for preparing the compounds.
公开/授权文献
- US10344018B2 Pyrazolylaminobenzimidazole derivatives as JAK inhibitors 公开/授权日：2019-07-09
信息查询
